Malvern Instruments Secures ?3 million from UK Government
Malvern Instruments (Malvern, UK) has secured £3 million support from the UK government’s Regional Growth Fund (RGF). The RGF is a competitive fund that was set up to support projects and programmes that are also raising private sector investment to create growth and sustainable employment. The funding is expected to lead to the creation of 47 new jobs in the UK over the next five years.
Malvern is a manufacturer of materials and biophysical characterization systems that are used in research, development, and manufacturing. Headquartered in Malvern in the UK, the company employs around 340 people, and has subsidiaries around the world in Europe, North America, China, Japan, and Korea exporting around 95% of its output.
Managing Director Paul Walker said: “This major boost for Malvern Instruments enables us make significant investments in UK R&D, applications development, and manufacturing engineering, to extend our links with UK universities and schools and to invest further in our apprentice programme.” He added: “It is good news not just for the company but also for the wider community in creating and securing employment opportunities and contributing further to the local economy.”
For more information visit:
www.bis.gov.uk/rgf
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.